antithrombotic/antiplatelet inhibitors (Medicure)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Nameantithrombotic/antiplatelet inhibitors (Medicure)
Drug Alias NameCanAm series (Medicure)CA-234CA-250MC-45308MC-45403 +[11] 
ClassificationSmall molecules
Mechanisms of ActionFactor IIa inhibitorsFactor Xa inhibitorsPlatelet aggregation inhibitors
TargetsProthrombinCoagulation factor X
Therapy Area/IndicationsThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMedicure Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedicure Inc
Active IndicationsN/A
Inactive IndicationsThrombosis

Other Information

ATC CodeN/A
Related LinksN/A